DK1159270T3 - Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon - Google Patents

Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon

Info

Publication number
DK1159270T3
DK1159270T3 DK00901555T DK00901555T DK1159270T3 DK 1159270 T3 DK1159270 T3 DK 1159270T3 DK 00901555 T DK00901555 T DK 00901555T DK 00901555 T DK00901555 T DK 00901555T DK 1159270 T3 DK1159270 T3 DK 1159270T3
Authority
DK
Denmark
Prior art keywords
methylpyridin
preparation
ethanone
methylsulfonyl
phenyl
Prior art date
Application number
DK00901555T
Other languages
Danish (da)
English (en)
Inventor
Erich Armbruster
Yves Bessard
David Kuo
James Edward Leresche
Ralf Proplesch
Jean-Paul Roduit
Original Assignee
Lonza Ag
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag, Merck & Co Inc filed Critical Lonza Ag
Application granted granted Critical
Publication of DK1159270T3 publication Critical patent/DK1159270T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK00901555T 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon DK1159270T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99100590 1999-01-14
US14599699P 1999-07-29 1999-07-29

Publications (1)

Publication Number Publication Date
DK1159270T3 true DK1159270T3 (da) 2004-02-23

Family

ID=34089809

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03024787T DK1394149T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon
DK00901555T DK1159270T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03024787T DK1394149T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon

Country Status (15)

Country Link
EP (2) EP1394149B1 (fr)
JP (1) JP4765167B2 (fr)
CN (2) CN1170820C (fr)
AT (2) ATE253559T1 (fr)
AU (1) AU2290800A (fr)
CA (2) CA2359958C (fr)
CZ (1) CZ302270B6 (fr)
DE (2) DE50009312D1 (fr)
DK (2) DK1394149T3 (fr)
ES (2) ES2235138T3 (fr)
HU (1) HUP0105124A3 (fr)
IL (1) IL143981A0 (fr)
PT (2) PT1159270E (fr)
SK (1) SK284903B6 (fr)
WO (1) WO2000042014A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104725300A (zh) * 2015-02-28 2015-06-24 宁波九胜创新医药科技有限公司 一种1-(6-甲基吡啶-3-基)-2-(4-甲磺酰基苯基)乙酮的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313683A (en) * 1963-04-22 1967-04-11 Lilly Co Eli Nematocidal and fungicidal methods
FR2074674A1 (en) * 1970-01-16 1971-10-08 Simafex Sulphonamide/aldehyde-bisulphite complexes - antibacterials with very high solubility in water
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
PL187848B1 (pl) * 1996-07-18 2004-10-29 Merck Frosst Canada Inc Podstawione pirydyny, kompozycja farmaceutyczna, podstawione pirydyny jako selektywne inhibitory cyklooksygenazy-2 oraz zastosowanie podstawionych pirydyn
TW492959B (en) * 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
AR015938A1 (es) * 1997-09-25 2001-05-30 Merck Sharp & Dohme Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
SK284805B6 (sk) * 1998-04-24 2005-11-03 Merck & Co., Inc. Spôsob syntézy 3,5-disubstituovaných-2-(fenyl alebo pyridyl)-pyridínov

Also Published As

Publication number Publication date
CA2485739C (fr) 2009-09-22
ATE287396T1 (de) 2005-02-15
JP2003518002A (ja) 2003-06-03
CA2359958A1 (fr) 2000-07-20
HUP0105124A2 (hu) 2002-04-29
EP1394149A1 (fr) 2004-03-03
CN1281589C (zh) 2006-10-25
DE50009312D1 (de) 2005-02-24
ES2209807T3 (es) 2004-07-01
CA2485739A1 (fr) 2000-07-20
CN1583723A (zh) 2005-02-23
DE50004327D1 (de) 2003-12-11
EP1394149B1 (fr) 2005-01-19
DK1394149T3 (da) 2005-04-04
HUP0105124A3 (en) 2002-05-28
JP4765167B2 (ja) 2011-09-07
PT1394149E (pt) 2005-05-31
CA2359958C (fr) 2006-04-04
WO2000042014A2 (fr) 2000-07-20
CZ302270B6 (cs) 2011-01-19
EP1159270B1 (fr) 2003-11-05
CN1170820C (zh) 2004-10-13
EP1159270A2 (fr) 2001-12-05
WO2000042014A3 (fr) 2000-12-07
CN1359374A (zh) 2002-07-17
SK284903B6 (sk) 2006-02-02
ES2235138T3 (es) 2005-07-01
ATE253559T1 (de) 2003-11-15
AU2290800A (en) 2000-08-01
PT1159270E (pt) 2004-03-31
SK9722001A3 (en) 2001-12-03
CZ20012457A3 (cs) 2002-01-16
IL143981A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DK1188747T3 (da) Phenoxypropylaminforbindelser
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20074311L (no) Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
NZ332057A (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds
MY147948A (en) 4- imidazolin-2-one compounds
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1159270T3 (da) Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
DE60002583D1 (de) Benzofurylpiperazine als serotonin-agonisten
DK1335913T3 (da) Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
ATE470442T1 (de) Verwendung von gamma-tocotrienol als diuretika
FR2827169B1 (fr) Durcisseur pour les ongles
DE59010091D1 (de) Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen
DK1370547T3 (da) Benzoxathiepin-derivater og anvendelse deraf som lægemidler
EA200100074A1 (ru) Способ лечения легочной гипертензии
HRP20020347B1 (en) Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
DK1117636T3 (da) Fremgangsmåde til fremstilling af trion-bis(oximether)derivater samt dermed opnåelige trion-mono- og trion-bis(oximether)derivater
DK1282619T3 (da) Fremgangsmåde til fremstilling af thiazolidindionderivater og mellemprodukter
MXPA01007169A (es) 1-(6-metilpiridin-3-il)-2-(4-(metilsulfonil)fenil)etanona y metodo para su elaboracion.
NZ336032A (en) Diphenylalkyl-tetrahydropyridines and use in pharmaceutical compositions